Hepatitis status, child-pugh classification, and serum AFP levels predict survival in patients treated with transarterial embolization for unresectable hepatocellular carcinoma

Journal of Gastrointestinal Surgery

Volumn 9, Issue 5, 2005, Pages 638-645

  Reichman, Trevor W ^a   Bahramipour, Phil ^a   Barone, Alison ^a   Koneru, Baburao ^a   Fisher, Adrian ^a   Contractor, Daniel ^a   Wilson, Dorian ^a   Dela Torre, Andrew ^a   Cho, Kyunghee C ^a   Samanta, Arun ^a   Harrison, Lawrence E ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Alpha fetoprotein; Embolization; Hepatocellular carcinoma

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; BILIRUBIN; DOXORUBICIN; MITOMYCIN;

ADULT; AGED; ANALYTIC METHOD; ARTIFICIAL EMBOLISM; BILIRUBIN BLOOD LEVEL; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEPATITIS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; REVIEW; SURGICAL TECHNIQUE; THROMBOCYTE COUNT; UNIVERSITY HOSPITAL;

EID: 20944432795     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2004.11.002     Document Type: Article

References (26)

1. H.B. El-Serag, and A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745 750
2. C. Cha, R.P. DeMatteo, and L.H. Blumgart Surgery and ablative therapy for hepatocellular carcinoma J Clin Gastroenterol 35 2002 130 137
3. D.C. Ihde, M.J. Matthews, R.W. Makuch, K.R. McIntire, J.L. Eddy, and L.B. Seeff Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy: Identification of two groups of patients with prospects for prolonged survival Am J Med 78 1985 399 406
4. G. Falkson, A. Cnaan, A.J. Schutt, L.M. Ryan, and H.C. Falkson Prognostic factors for survival in hepatocellular carcinoma Cancer Res 48 1988 7314 7318
5. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival Hepatology 37 2002 429 442
6. D.Y. Lin, Y.F. Liaw, T.Y. Lee, and C.M. Lai Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma: A randomized controlled trial Gastroenterology 94 1988 453 456
7. G. Pelletier, M. Ducreux, F. Gay, M. Luboinski, H. Hagege, T. Dao, W. Van Steenbergen, C. Buffet, P. Rougier, M. Adler, J.P. Pignon, A. Roche, and the Group CHC Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: A multicenter randomized trial J Hepatol 29 1998 129 134
8. M.V. Madden, J.E. Krige, S. Bailey, S.J. Beningfield, C. Geddes, I.D. Werner, and J. Terblanche Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma Gut 34 1993 1598 1600
9. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire N Engl J Med 332 1995 1256 1261
10. J. Bruix, J.M. Llovet, A. Castells, X. Montana, C. Bru, M.C. Ayuso, R. Vilana, and J. Rodes Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: Results of a randomized, controlled trial in a single institution Hepatology 27 1998 1578 1583
11. J.M. Llovet, M.I. Real, X. Montana, R. Planas, S. Coll, J. Aponte, C. Ayuso, M. Sala, J. Muchart, R. Sola, J. Rodes, and J. Bruix Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial Lancet 359 2002 1734 1739
12. C.M. Lo, H. Ngan, W.K. Tso, C.L. Liu, C.M. Lam, R.T. Poon, S.T. Fan, and J. Wong Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma Hepatology 35 2002 1171
13. R.T. Poon, H. Ngan, C.M. Lo, C.L. Liu, S.T. Fan, and J. Wong Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence J Surg Oncol 73 2000 109 114
14. C.B. O'Suilleabhain, R.T. Poon, J.L. Yong, G.C. Ooi, W.K. Tso, and S.T. Fan Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma Br J Surg 90 2003 325 331
15. M.F. Yuen, A.O. Chan, B.C. Wong, C.K. Hui, G.C. Ooi, W.K. Tso, H.J. Yuan, D.K. Wong, and C.L. Lai Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: Results of a comparative study in 96 Chinese patients Am J Gastroenterol 98 2003 1181 1185
16. M.C.. Yu, and J.M. Yuan Environmental factors and risk for hepatocellular carcinoma Gastroenterolog 127 Suppl 1 2004 72 78
17. L. Lladó, J. Virgili, J. Figueras, C. Valls, J. Dominguez, A. Rafecas, J. Torras, J. Fabregat, J. Guardiola, and E. Jaurrieta A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization Cancer 88 2000 50 87
18. S. Savastano, D. Miotto, G. Casarrubea, S. Teso, M. Chiesura-Corona, and G.P. Feltrin Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with Child's grade A or B cirrhosis: A multivariate analysis of prognostic factors J Clin Gastroenterol 28 1999 334 340
19. C. Cha, Y. Fong, W.R. Jarnagin, L.H. Blumgart, and R.P. DeMatteo Predictors and patterns of recurrence after resection of hepatocellular carcinoma J Am Coll Surg 197 2003 753 758
20. L.E. Harrison, B. Koneru, P. Baramipour, A. Fisher, A. Barone, D. Wilson, A. Dela Torre, K.C. Cho, D. Contractor, and M. Korogodsky Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma J Am Coll Surg 197 2003 759 764
21. M. Pompili, G.L. Rapaccini, F. De Luca, E. Caturelli, A. Astone, D.A. Siena, M.R. Villani, A. Grattagliano, A. Cedrone, and G. Gasbarrini Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection Cancer 79 1997 1501 1508
22. K. Takayasu, Y. Shima, Y. Muramatsu, N. Moriyama, T. Yamada, M. Makuuchi, H. Hasegawa, and S. Hirohashi Hepatocellular carcinoma: Treatment with intraarterial iodized oil with and without chemotherapeutic agents Radiology 163 1987 345 351
23. J.M. Chang, W.S. Tzeng, H.B. Pan, C.F. Yang, and K.H. Lai Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma: A randomized controlled study Cancer 74 1994 2449 2453
24. S. Kawai, J. Okamura, M. Ogawa, Y. Ohashi, M. Tani, J. Inoue, Y. Kawarada, M. Kusano, Y. Kubo, and C. Kuroda Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma - a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer Treatment of Japan Cancer Chemother Pharmacol 31 Suppl 1992 S1 S6
25. T.M. Block, A.S. Mehta, C.J. Fimmel, and R. Jordan Molecular viral oncology of hepatocellular carcinoma Oncogene 22 2003 5093 5107
26. W. Kim, S. Oe Lim, J.S. Kim, Y.H. Ryu, J.Y. Byeon, H.J. Kim, Y.I. Kim, J.S. Heo, Y.M. Park, and G. Jung Comparison of proteome between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma Clin Cancer Res 9 2003 5493 5500